NCT00706420View on ClinicalTrials.gov

Islet Transplantation Alone (ITA) in Patients With Difficult to Control Type I Diabetes Mellitus Using a Glucocorticoid-free Immunosuppressive Regimen

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

April 7, 2004

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2025

Conditions
Diabetes Mellitus
Interventions
PROCEDURE

Islet Transplantation + Immunosuppression

Islet Transplantation + Immunosuppression (Sirolimus/Tacrolimus, daclizumab)

BIOLOGICAL

Islet cell transplantation

Islet cell transplantation will occur through the portal vein.

Trial Locations (1)

91010

City of Hope Medical Center, Duarte

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

lead

City of Hope Medical Center

OTHER